Marketing-authorisation holder Β· Canada
Canada Life Sciences
5 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DIPYRONE50 % Β· Solution | Dipirona | Canada | Cancelled | |
| ERYTHROMYCIN462.4 mg / g Β· Powder For Solution | Erythromycin | Canada | Cancelled | |
| NEOMYCIN SULFATE568.75 mg / g Β· Powder For Solution | Neomycin | Canada | Cancelled | |
| OXYTET 10001000 mg / g Β· Powder For Solution | Oxytetracycline | Canada | Cancelled | |
| TETRACYCLINE 10001000 mg / g Β· Powder For Solution | Tetracycline | Canada | Cancelled |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 5 | 0 | 5 | CompaniesAll medicines |



